BioSig Technologies Inc. - רווח החברה לפני מסים, ריבית ופחת BSGM

Biosig Technologies (BSGM) is implementing software robotics for the precise calibration of cardiac devices to minimize human error. Current financial momentum remains weak, while business resilience is supported by resource optimization. The EBITDA cash volume reflects actual sales without accounting distortions, with the metric holding at . The scalability of the ECG filtration system is based on the sale of high-margin disposable catheters and proprietary software.

The stability of Biosig Technologies (BSGM) relies on the retention of highly skilled engineers through R&D-intensive IT developments, which directly converts into the size of its cash EBITDA. This metric accumulates daily operating profit before depreciation and taxes, excluding paper adjustments to reveal actual cash flow, which allows for an objective assessment of the business's intrinsic value and the risks of a drawdown.